Substances for the treatment and prophylaxis of macular degeneration
Age-related macular degeneration (AMD) is differentiated into a ?dry? and a ?wet? form of progression. With approx. 85 % of cases, dry AMD occurs far more often. With this form of the disease, over a period of several years, loss of light-sensitive cells in the retina occurs. One cause, amongst others, is the accumulation of a retinoid component, A2E (N-retinyl-N-retinylidene ethanolamine) in the macular region, above all in RPE cells (retinal pigment epithelial cells). That A2E induces apoptosis in RPE cells is known.<br><br>
In this context, new substances are introduced which bind A2E (N-retinyl-N-retinylidene ethanolamine) and prevent the apoptosis induced by A2E in RPE cells (retinal pigment epithelial cells). These new substances are suitable for the (acute) treatment and prophylaxis of patients with dry AMD, whereby the success of the treatment can be determined easily by a decrease of lipofuscin fluorescence in the macula.
Further Information: PDF
TransMIT Gesellschaft für Technologietransfer mbH
Phone: +49 (0)641/943 64-12
Contact
Dr. Peter Stumpf
Media Contact
All latest news from the category: Technology Offerings
Newest articles
“Nanostitches” enable lighter and tougher composite materials
In research that may lead to next-generation airplanes and spacecraft, MIT engineers used carbon nanotubes to prevent cracking in multilayered composites. To save on fuel and reduce aircraft emissions, engineers…
Trash to treasure
Researchers turn metal waste into catalyst for hydrogen. Scientists have found a way to transform metal waste into a highly efficient catalyst to make hydrogen from water, a discovery that…
Real-time detection of infectious disease viruses
… by searching for molecular fingerprinting. A research team consisting of Professor Kyoung-Duck Park and Taeyoung Moon and Huitae Joo, PhD candidates, from the Department of Physics at Pohang University…
